 		 		 			  		 		 			we are a delaware corporation incorporated in 1983 we develop manufacture and distribute products and provide services primarily for the companion animal veterinary livestock and poultry water testing and dairy markets we also sell a line of portable electrolytes and blood gas analyzers for the human pointofcare medical diagnostics market our primary products and services are 		 		 			  		 		 			 				  			 		 			 			pointofcare veterinary diagnostic products comprising instruments consumables and rapid assays 		 			 				  			 		 			 			veterinary reference laboratory diagnostic and consulting services 		 			 				  			 		 			 			practice management systems and services and digital imaging systems used by veterinarians 		 			 				  			 		 			 			biological materials testing laboratory animal diagnostic instruments and services used by the biomedical research community 		 			 				  			 		 			 			diagnostic healthmonitoring and food safety testing products for livestock poultry and dairy 		 			 				  			 		 			 			products that test water for certain microbiological contaminants  		 			 				  			 		 			 			pointofcare electrolytes and blood gas analyzers used in the human pointofcare medical diagnostics market 		 			  		 		 		 		  		 			4 		 		 			 		   		 			 		 		 			 		  		 		 		 			description of business by segment 		 		 			  		 		 			prior to january 1 2013 we operated primarily through three business segments diagnostic and information technologybased products and services for the veterinary market which we continue to refer to as the companion animal group cag water quality products water and diagnostic products for livestock and poultry health which we referred to as livestock and poultry diagnostics we also operated two smaller operating segments that comprised products for milk quality and safety dairy and products for the human pointofcare medical diagnostics market opti medical financial information about our dairy and opti medical operating segments was combined and presented with our remaining pharmaceutical product line and our outlicensing arrangements in an other category because they did not meet the quantitative or qualitative thresholds for reportable segments  		 		 			  		 		 			in 2013 we combined the management of our livestock and poultry diagnostics and dairy lines of business to more effectively realize the market synergies between the product lines and to achieve operational efficiencies we refer to this segment as livestock poultry and dairy lpd our opti medical operating segment remains combined and presented with our remaining pharmaceutical product line and our outlicensing arrangements in an other category because they do not meet the quantitative or qualitative thresholds for reportable segments the segment income loss from operations discussed within this report for the year ended december 31 2012 has been retrospectively revised to reflect this change in the composition of our reportable segments see note 14 to the consolidated financial statements for the year ended december 31 2014 included in this annual report on form 10k for financial information about our segments including our product and service categories and our geographic areas 		 		 			  		 		 			the performance of our business is particularly subject to various risks that are associated with doing business internationally for the year ended december 31 2014 sales of products and services to customers outside the us accounted for approximately 43 of our overall revenue these foreign sales accounted for approximately 36 52 and 90 of revenue in our cag water and lpd segments respectively see part 1 